Surgery, venous thrombosis and anti-Xa

Area of Science:

• Thrombosis and Hemostasis
• Surgical Complications
• Pharmacology

Background:

• Deep venous thrombosis (DVT) is a frequent and unpredictable surgical complication.
• Identifying patients at high risk for DVT is crucial for preventative strategies.

Purpose of the Study:

• To investigate if preoperative levels of anti-Xa, a natural coagulation inhibitor, can predict DVT development.
• To explore the association between oral contraceptive use, anti-Xa levels, and DVT incidence.
• To determine the predictive value of anti-Xa levels in patients undergoing major orthopedic surgery.

Main Methods:

• Comparative analysis of preoperative anti-Xa levels in women using oral contraceptives versus controls.
• Measurement of preoperative anti-Xa levels in patients undergoing total hip replacement, correlating with DVT occurrence.
• Statistical analysis to determine the significance of anti-Xa levels in DVT prediction.

Main Results:

• Women on oral contraceptives exhibited significantly lower preoperative anti-Xa levels and a higher incidence of DVT post-emergency surgery.
• Patients who developed DVT after total hip replacement had significantly lower mean preoperative anti-Xa levels.
• A high percentage (94%) of patients with preoperative anti-Xa levels below 80% developed DVT.

Conclusions:

• Preoperative anti-Xa levels serve as a potential predictive marker for identifying patients at risk of developing DVT.
• Low anti-Xa levels may indicate an increased susceptibility to postoperative thrombosis.
• Findings suggest a mechanism for postoperative thrombosis and enable patient selection for preventative interventions.